• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Signify Research | Healthcare Technology Market Intelligence

Analysis: US Ambulatory EHR Market Shake-Up at HIMSS 2022

by Alex Green, Director at Signify Research 03/31/2022 Leave a Comment

Analysis: US Ambulatory EHR Market Shake-up at HIMSS 2022

During, and in the run-up to, HIMSS earlier this month there were several announcements from US EHR vendors that will shake up the US EHR market, particularly in the ambulatory segment. These included:  - Allscripts’ announcement that it is to sell its Sunrise, Paragon, TouchWorks, Opal, dbMotion, STAR and HealthQuest business to Harris Computer Corp. - Meditech’s announcement that Expanse Ambulatory is to be made available to independent and physician-owned practices, alongside its
Read More

Ventilator Consumables Market Analysis: COVID-19 Pandemic Repercussions

by Kelly Patrick, Principal Analyst at Signify Research 02/25/2022 Leave a Comment

Consumables are often associated with low-cost, standardized products. This has often been the case with breathing system solutions used in ventilation. However, the COVID-19 pandemic has highlighted the importance of sufficient infection control in the hospital environment, subsequently uplifting demand for solutions that reduce infection risk. Vendors of all calibers grabbed this opportunity to expand market share, but questions remain on whether they will keep up in a crowded and
Read More

Post-COVID Telehealth in Europe: What Works for Primary Care? – Analysis

by Alex Green, Director at Signify Research 06/17/2021 Leave a Comment

Post-COVID Telehealth in Europe – What Works for Primary Care? - Analysis

The European primary care telehealth market has been transformed since the outbreak of COVID-19 more than 15 months ago. But which countries have developed an ecosystem that is primed for long-term growth that will bring value and improved processes to both healthcare providers and patients? A key starting point is to define the vendors that serve primary care telehealth. There are two types of company that address this market. - Telehealth Service Providers – These are companies that sell
Read More

Dedalus Completes Acquisition of DXC’s Provider Healthcare Business – M&A Analysis

by Alex Green, Director at Signify Research 04/09/2021 Leave a Comment

Dedalus Completes Acquisition of DXC’s Provider Healthcare Business - M&A Analysis

What You Should Know: Last week saw Dedalus complete the purchase of DXC’s healthcare provider business for $450M, a deal that was originally announced in July 2020.   - DXC was created in 2017 via the merger of CSC and the Enterprise Services business of Hewlett Packard Enterprise (HPE) - Dedalus has been through a rapid acquisition program over the last ten years acquiring a majority position with France-based Medasys/Noemalife in 2016 and then acquiring the EHR and integrated care
Read More

How Will Philips Acquisition of BioTelemetry Impact The Cardiac Monitoring Market?

by Kelly Patrick, Principal Analyst at Signify Research 02/09/2021 Leave a Comment

M&A: Philips Acquires Remote Cardiac Monitoring Platform BioTelemetry for $2.8B

At the end of December 2020, Philips announced the planned acquisition of BioTelemetry for $2.8 billion in cash. - BioTelemetry was formed in 2013 after a series of acquisitions from the initial founding company CardioNet, Inc. - CardioNet, Inc. based in San Diego, USA was initially founded in 1994. - After a multitude of acquisitions in recent years, BioTelemetry has established itself as a leading cardiac powerhouse, specializing in mobile and wireless medical technology. After this
Read More

Will Nanox Disrupt The X-Ray Systems Market?

by Alan Stoddart, Editor at Signify Research 11/03/2020 Leave a Comment

Will Nanox Disrupt the X-ray Systems Market?

With its share price falling from more than $66 to less than $24, September was a tumultuous month for Nanox. On August 25th, the medical imaging start-up closed its initial public offering, having raised $190m from the sale of 10,555,556 ordinary shares at a price of $18 each. Money poured in as investors were sold on Nanox’s cold cathode x-ray source and the subsequent reduction in costs that it would enable, as well as the vendor’s pay-per-scan pricing model that would let the company
Read More

The Future of the ICU? How Clinical Decision Support Is Advancing Care

by Kelly Patrick, Principal Analyst at Signify Research 10/19/2020 Leave a Comment

The Future of the ICU? How Clinical Decision Support Is Advancing Care

Without a doubt 2020 has been a devastating year for many; the impact of COVID-19 on both personal lives and businesses has had long-term consequences. At the end of September, the number of COVID-19 cases fell just short of 350 million, with just over 1 million deaths reported. The expectation of a second peak in many countries exposed to the deadly illness is being handled with care, with many governments attempting to minimize the impact of an extreme rise in cases.   COVID-19
Read More

AmWell IPO and Google Deal – Five Key Takeaways to Know

by Alex Green, Director at Signify Research 09/10/2020 Leave a Comment

AmWell IPO and Google Deal – Five Key Takeaways to Know

1) COVID-19 Has Driven Revenue Up 77% The headline revenue data (summarised below) provides very positive news for AmWell and its new investor, Google. Notably: - Even prior to COVID-19, the company was growing well with revenues increasing by 31% in 2019 compared to 2018. - This rate of growth has accelerated in 1H20, with overall revenue up 77% in the same period in 2019. - The 2019 growth was partly driven by a small increase in the number of health plan subscription customers and
Read More

Why International Expansion Must Remain a Priority for Cerner, Epic, Allscripts, MEDITECH

by Arun Gill, Senior Analyst at Signify Research 08/24/2020 Leave a Comment

Why International Expansion Must Remain a Priority for Cerner, Epic, Allscripts, MEDITECH

What You Should Know: - How the top US acute EHR vendors, namely Cerner, Epic, Allscripts, and MEDITECH (+85% share of US acute market in terms of revenues), have progressed on international expansion. As highlighted below, there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Cerner has by far the highest revenue at more than $650M in 2019, representing 12% of its business. Whilst MEDITECH has considerably lower revenue than
Read More

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical

by Steve Holloway, Director at Signify Research 08/07/2020 Leave a Comment

M&A Analysis: 3 Benefits of Siemens Healthineers $16.4B Acquisition of Varian Medical

What You Should Know: - Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. - Deal expected to close in 1H 2021. - Varian Medical will maintain its brand name and operate “independently” - Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as part of the transaction. News of the deal between Siemens Healthineers and Varian Medical will have caught many industry onlookers off guard on Sunday evening.
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |